-
Clinical Trials for Neurodegenerative Diseases
Research that focuses on new treatments for patients with neurodegenerative diseases
Learn More
Clinical Trials
Clinical trials are the primary way to determine if a new form of treatment or prevention is safe and effective.
Clinical Hours
Monday-Friday: 8 AM – 4 PM
Address
45 Resnik Road, Suite 205
Plymouth, MA 02360
Phone
Request Information
If you are interested in receiving information about the clinical trials that are being conducted at our site, please complete the form below and a member of our team will contact you.
Headlands Research Eastern MA Services
EMG
This test measures the electrical activity of the muscles when they are working to contract and when they are at rest. EMG testing is used to diagnose conditions that cause muscle tissue damage or damage to the junctions between the muscles and nerves. We perform these on-site.
Lumbar Punctures
This test is also known as a spinal tap. A needle is inserted into the spinal canal, to collect cerebrospinal fluid (CSF) for diagnostic testing. The main reason for a lumbar puncture is to help diagnose diseases of the central nervous system, including the brain and spine. We perform these lumbar punctures here in the office on-site.
EKG
Venipuncture
We have a small laboratory on-site that collects blood tubes for research studies. We are able to process these specimens and ship them for analysis. Our staff members are IATA certified and our laboratory has a CLIA waiver.
Urinalysis
As part of our research studies, we collect urine specimens for routine analysis.
Meet our Team
Kinan Hreib MD, PhD, MBA
Dr. Hreib obtained his MD, Ph.D. and M.B.A. From Boston University and was trained in medicine and Neurology at Boston University Medical Center and Boston City Hospital. His professional life as a neurologist began at Lahey Clinic in Burlington, MA, where he was the director of Vascular Neurology for over twenty years, after which he became the chief of Neurology at Mount Auburn Hospital in Cambridge, MA before becoming the Chief Medical Officer for Baystate Health North. Dr. Hreib continued to see patients as a neurologist while the chief medical executive and later decided to join Donald Marks clinic on neurodegenerative disease in Plymouth.
Rachel Lamontagne, FNP-C
Rachel is a board-certified Family Nurse Practitioner with a strong background in adult and geriatric care. She brings a unique blend of clinical expertise and analytical insight, holding dual degrees in Economics and Nursing from the University of Massachusetts. Rachel earned her Family Nurse Practitioner certification from Regis College and has since dedicated her career to advancing care for adults with complex and degenerative conditions. Known for her compassionate approach and commitment to excellence, Rachel strives to deliver personalized, evidence-based care that helps patients live with dignity and purpose.
Shelby Donath, FNP-BC
Shelby is a nurse practitioner specializing in neurodegenerative diseases, with a strong background in both clinical care and research. She holds a Master of Science in Nursing from Simmons University, where she completed her Family Nurse Practitioner training. Her professional journey began in oncology nursing, where she gained valuable experience caring for patients with complex medical needs. During her graduate studies, she further deepened her clinical and academic focus on neurological conditions, contributing to research efforts in this area. She is passionate about advancing care for individuals affected by neurodegenerative disorders through evidence-based practice, clinical research, and compassionate, patient-centered care.
Meghan Prentiss, PA-C
Meghan is a highly experienced physician assistant with over 20 years of clinical practice, primarily in neurosurgery and physiatry. Her background includes everything from neurocritical care to outpatient management, giving her a deep understanding of the full continuum of neurological care. Meghan earned her PA degree from the University of New England after completing her undergraduate studies in biology at Brown University. In 2024, she completed the Geriatric Champion Program at Brigham and Women’s Hospital, further strengthening her expertise in the care of older adults. Since joining our team in April 2025, Meghan has been committed to providing compassionate, personalized care for individuals living with neurodegenerative conditions.
Interested in learning more about Clinical Trials?
Please complete the form below and one of our staff will contact you shortly.
"*" indicates required fields
